293 related articles for article (PubMed ID: 30041024)
1. Testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists.
Lobo J; Costa AL; Vilela-Salgueiro B; Rodrigues Â; Guimarães R; Cantante M; Lopes P; Antunes L; Jerónimo C; Henrique R
Hum Pathol; 2018 Dec; 82():113-124. PubMed ID: 30041024
[TBL] [Abstract][Full Text] [Related]
2. The Significance of Spermatic Cord Involvement by Testicular Germ Cell Tumors: Should We Be Staging Discontinuous Invasion From Involved Lymphovascular Spaces Differently From Direct Extension?
Sanfrancesco JM; Trevino KE; Xu H; Ulbright TM; Idrees MT
Am J Surg Pathol; 2018 Mar; 42(3):306-311. PubMed ID: 29309304
[TBL] [Abstract][Full Text] [Related]
3. Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?
Scandura G; Wagner T; Beltran L; Alifrangis C; Shamash J; Berney DM
Mod Pathol; 2021 Apr; 34(4):834-841. PubMed ID: 33319858
[TBL] [Abstract][Full Text] [Related]
4. [Importance of pathology for therapy planning of testicular germ cell tumors].
Heidenreich A; Knüchel-Clarke R; Pfister D
Pathologe; 2014 May; 35(3):266-73. PubMed ID: 24771259
[TBL] [Abstract][Full Text] [Related]
5. Interobserver Agreement in Vascular Invasion Scoring and the Added Value of Immunohistochemistry for Vascular Markers to Predict Disease Relapse in Stage I Testicular Nonseminomas.
Lobo J; Stoop H; Gillis AJM; Looijenga LHJ; Oosterhuis W
Am J Surg Pathol; 2019 Dec; 43(12):1711-1719. PubMed ID: 31490238
[TBL] [Abstract][Full Text] [Related]
6. Do Histopathologic Variables Affect the Reporting of Lymphovascular Invasion in Testicular Germ Cell Tumors?
French BL; Zynger DL
Am J Clin Pathol; 2016 Mar; 145(3):341-9. PubMed ID: 27124916
[TBL] [Abstract][Full Text] [Related]
7. Reprint of: Updates in 2022 on the staging of testicular germ cell tumors.
Canete Portillo S; Rais-Bahrami S; Magi-Galluzzi C
Hum Pathol; 2023 Mar; 133():153-161. PubMed ID: 36898947
[TBL] [Abstract][Full Text] [Related]
8. Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study.
Sesterhenn IA; Weiss RB; Mostofi FK; Stablein DM; Rowland RG; Falkson G; Rivkind SE; Vogelzang NJ
J Clin Oncol; 1992 Jan; 10(1):69-78. PubMed ID: 1309382
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of the American Joint Committee on Cancer (AJCC) 8th edition update in seminoma pT1 subclassification.
Fontes-Sousa M; Lobo J; Magalhães H; Cassis J; Malheiro M; Ramos S; Henrique R; Martins A; Maurício MJ
BMC Urol; 2020 Aug; 20(1):127. PubMed ID: 32819326
[TBL] [Abstract][Full Text] [Related]
10. Pathological risk factors for metastatic disease at presentation in testicular seminomas with focus on the recent pT changes in AJCC TNM eighth edition.
Scandura G; Wagner T; Beltran L; Alifrangis C; Shamash J; Berney DM
Hum Pathol; 2019 Dec; 94():16-22. PubMed ID: 31666197
[TBL] [Abstract][Full Text] [Related]
11. Testicular Tumors: A Contemporary Update on Morphologic, Immunohistochemical and Molecular Features.
Al-Obaidy KI; Idrees MT
Adv Anat Pathol; 2021 Jul; 28(4):258-275. PubMed ID: 33871428
[TBL] [Abstract][Full Text] [Related]
12. Updates in 2022 on the staging of testicular germ cell tumors.
Canete Portillo S; Rais-Bahrami S; Magi-Galluzzi C
Hum Pathol; 2022 Oct; 128():152-160. PubMed ID: 35926809
[TBL] [Abstract][Full Text] [Related]
13. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
Kojima T; Kawai K; Tsuchiya K; Abe T; Shinohara N; Tanaka T; Masumori N; Yamada S; Arai Y; Narita S; Tsuchiya N; Habuchi T; Nishiyama H
Int J Urol; 2015 Oct; 22(10):923-7. PubMed ID: 26094715
[TBL] [Abstract][Full Text] [Related]
14. Do Nonseminomatous Germ Cell Tumors of the Testis With Lymphovascular Invasion of the Spermatic Cord Merit Staging as pT3?
Gordetsky J; Sanfrancesco J; Epstein JI; Trevino K; Xu H; Osunkoya A; Xiao GQ; Kao CS; Unger P; Hashemi-Sadraei N; Albany C; Jorns JM; Lu DY; Matoso A; Rais-Bahrami S; Schwartz LE; Ulbright TM; Idrees MT
Am J Surg Pathol; 2017 Oct; 41(10):1397-1402. PubMed ID: 28719463
[TBL] [Abstract][Full Text] [Related]
15. [Clinical presentation of testicular germinal cancer].
Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A
World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic analysis of choriocarcinoma as a pure or predominant component of germ cell tumor of the testis.
Alvarado-Cabrero I; Hernández-Toriz N; Paner GP
Am J Surg Pathol; 2014 Jan; 38(1):111-8. PubMed ID: 24145647
[TBL] [Abstract][Full Text] [Related]
18. Updates in Staging and Reporting of Testicular Cancer.
Magers MJ; Idrees MT
Surg Pathol Clin; 2018 Dec; 11(4):813-824. PubMed ID: 30447843
[TBL] [Abstract][Full Text] [Related]
19. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.
Cohn-Cedermark G; Stahl O; Tandstad T;
Andrology; 2015 Jan; 3(1):102-10. PubMed ID: 25270123
[TBL] [Abstract][Full Text] [Related]
20. [Testicular germ cell tumors: Histopathological and molecular features].
Tourne M; Radulescu C; Allory Y
Bull Cancer; 2019 Apr; 106(4):328-341. PubMed ID: 30905378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
